ANIX

Anixa Biosciences Inc

Jun 23 • 10:45AM ET

2.81

+0.04 1.44 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.45%	Shs Outstand	33.92M	Perf Week	13.31%
Market Cap	95.60M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	1.86%	Shs Float	32.17M	Perf Month	2.18%
Enterprise Value	80.84M	PEG	-	EPS next Q	-0.08	Inst Own	14.97%	Short Float	3.15%	Perf Quarter	7.66%
Income	-10.03M	P/S	-	EPS this Y	3.92%	Inst Trans	-2.96%	Short Ratio	7.71	Perf Half Y	-13.27%
Sales	0.00M	P/B	6.59	EPS next Y	-3.06%	ROA	-63.02%	Short Interest	1.01M	Perf YTD	-9.94%
Book/sh	0.43	P/C	6.98	EPS next 5Y	-2.86%	ROE	-65.70%	52W High	5.46 -48.50%	Perf Year	-19.48%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-68.66%	52W Low	2.32 21.12%	Perf 3Y	-17.11%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.97% 6.47%	Perf 5Y	-29.40%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.64%	Oper. Margin	-	ATR (14)	0.18	Perf 10Y	-15.87%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	13.51%	SMA20	7.91%	Beta	0.60	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	0.39%	Rel Volume	0.80	Prev Close	2.77
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-14.87%	Avg Volume	131.38K	Price	2.81
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	24,467	Change	1.44%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)